购物车
全部删除
您的购物车当前为空
别名 IN-10018 tosylate, BI-853520 tosylate
Ifebemtinib (tosylate)(BI-853520 (tosylate); IN-10018 (tosylate))是一种针对PTK2激酶的高选择性抑制剂,具有抗肿瘤活性。该化合物能够抑制前列腺癌细胞中FAK的自身磷酸化,并抑制体内球状体的形成及原位肿瘤的生长。Ifebemtinib (tosylate) 可用于实体瘤、乳腺癌和恶性胸膜间皮瘤等癌症研究。

Ifebemtinib (tosylate)(BI-853520 (tosylate); IN-10018 (tosylate))是一种针对PTK2激酶的高选择性抑制剂,具有抗肿瘤活性。该化合物能够抑制前列腺癌细胞中FAK的自身磷酸化,并抑制体内球状体的形成及原位肿瘤的生长。Ifebemtinib (tosylate) 可用于实体瘤、乳腺癌和恶性胸膜间皮瘤等癌症研究。

Ifebemtinib tosylate 相关产品
| 产品描述 | Ifebemtinib (tosylate) (BI-853520 (tosylate); IN-10018 (tosylate)) is a highly selective PTK2 kinase inhibitor with anti-tumor properties. It inhibits FAK autophosphorylation in prostate cancer cells and suppresses spheroid formation and in situ tumor growth in vivo. Ifebemtinib (tosylate) is applicable in cancer research, including studies on solid tumors, breast cancer, and malignant pleural mesothelioma. |
| 别名 | IN-10018 tosylate, BI-853520 tosylate |
| 分子量 | 760.76 |
| 分子式 | C35H36F4N6O7S |
| CAS No. | 2761021-80-9 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容